Nicola Wealth Management LTD. purchased a new stake in Clorox Co (NYSE:CLX) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 19,100 shares of the company’s stock, valued at approximately $2,542,000.
Other large investors have also made changes to their positions in the company. Advisor Group Inc. lifted its holdings in shares of Clorox by 26.8% in the 4th quarter. Advisor Group Inc. now owns 48,896 shares of the company’s stock valued at $7,276,000 after acquiring an additional 10,335 shares during the last quarter. State of Tennessee Treasury Department lifted its holdings in shares of Clorox by 113.5% in the 4th quarter. State of Tennessee Treasury Department now owns 74,836 shares of the company’s stock valued at $11,131,000 after acquiring an additional 39,790 shares during the last quarter. Quadrature Capital Ltd bought a new position in shares of Clorox in the 4th quarter valued at about $2,869,000. Baird Financial Group Inc. lifted its holdings in shares of Clorox by 1.5% in the 4th quarter. Baird Financial Group Inc. now owns 51,054 shares of the company’s stock valued at $7,594,000 after acquiring an additional 740 shares during the last quarter. Finally, Standard Life Aberdeen plc lifted its holdings in shares of Clorox by 1.9% in the 4th quarter. Standard Life Aberdeen plc now owns 36,918 shares of the company’s stock valued at $5,492,000 after acquiring an additional 675 shares during the last quarter. 76.05% of the stock is owned by hedge funds and other institutional investors.
Shares of Clorox opened at $126.95 on Friday, according to Marketbeat.com. The company has a quick ratio of 0.93, a current ratio of 1.18 and a debt-to-equity ratio of 2.14. The stock has a market capitalization of $16.42 billion, a price-to-earnings ratio of 23.73, a PEG ratio of 2.88 and a beta of 0.39. Clorox Co has a 1 year low of $113.57 and a 1 year high of $150.40.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, May 2nd. The company reported $1.37 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.31 by $0.06. The business had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.51 billion. Clorox had a net margin of 13.27% and a return on equity of 107.93%. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.31 earnings per share. sell-side analysts predict that Clorox Co will post 5.66 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 17th. Shareholders of record on Wednesday, August 1st will be paid a $0.96 dividend. This represents a $3.84 annualized dividend and a yield of 3.02%. The ex-dividend date is Tuesday, July 31st. Clorox’s payout ratio is currently 71.78%.
Clorox announced that its Board of Directors has initiated a stock buyback program on Thursday, May 24th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to reacquire up to 12.6% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its shares are undervalued.
A number of research analysts recently commented on the stock. BMO Capital Markets set a $147.00 price target on shares of Clorox and gave the company a “buy” rating in a report on Thursday, March 29th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $138.00 price target (down previously from $139.00) on shares of Clorox in a report on Tuesday, March 13th. Morgan Stanley lowered their price target on shares of Clorox from $133.00 to $128.00 and set an “equal weight” rating for the company in a report on Thursday, April 5th. Zacks Investment Research downgraded shares of Clorox from a “hold” rating to a “sell” rating in a report on Monday, April 9th. Finally, Barclays set a $131.00 price target on shares of Clorox and gave the company a “hold” rating in a report on Friday, April 6th. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $130.98.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.